相关实验视频
Updated: Jan 25, 2026

A Gut-on-a-Chip Model to Study the Gut Microbiome-Nervous System Axis
Published on: July 28, 2023
肠道微生物组和肥胖症护理:弥合饮食,手术和药物干预的桥梁
Davide Masi1, Mikiko Watanabe2, Karine Clément3
1Sorbonne Université, Inserm, Nutrition and Obesities: Systemic Approaches, NutriOmics Research Unit, 75013 Paris, France; Sapienza University of Rome, Department of Experimental Medicine, Section of Medical Physiopathology, Food Science and Endocrinology, 00161 Rome, Italy.
肠道微生物组通过影响新陈代谢和炎症显著影响肥胖. 整合微生物组数据的个性化治疗可以彻底改变肥胖护理,并补充新的药物.
科学领域:
- 微生物学 微生物学
- 代谢过程中的代谢.
- 肥胖问题研究研究
背景情况:
- 早期的小鼠研究将肠道微生物群与能量平衡和炎症联系起来.
- 显著的进展已经阐明了肠道微生物组在肥胖中的复杂作用.
- 微生物代谢产物如SCFA和胆酸是主要的代谢调节剂.
研究的目的:
- 审查对肠道微生物群对肥胖的影响不断演变的理解.
- 突出微生物代谢产物和多组体在肥胖研究中的作用.
- 讨论将微生物组数据整合到个性化肥胖干预中.
主要方法:
- 审查机械学和多学科研究.
- 确定关键的微生物代谢物及其功能.
- 分析微生物组研究的技术进步.
主要成果:
- 微生物代谢物极大地调节宿主代谢,炎症和肠-大脑轴.
- 大基因组和多基因组数据为宿主微生物相互作用提供了深入的见解.
- 基于微生物组资料的表型分层对于肥胖研究至关重要.
结论:
- 肠道微生物组数据集成可以为肥胖亚型提供有针对性的干预措施.
- 基于微生物组的个性化疗法对预防和治疗肥胖有希望.
- 需要进一步的研究,以将微生物组疗法与新兴的抗肥胖药物相结合.
更多相关视频
08:38Application of Flow Vermimetry for Quantification and Analysis of the Caenorhabditis elegans Gut Microbiome
Published on: March 31, 2023
08:49Assessing Changes in Volatile General Anesthetic Sensitivity of Mice after Local or Systemic Pharmacological Intervention
Published on: October 16, 2013
相关概念视频
Peptic Ulcer Disease V: Surgical Management and Nursing Care
Surgical Interventions for Peptic Ulcer Disease
Design Example: Strain Gauge Bridge or Wheatstone Bridge
Obesity
Dietary Connections
Bridge rectifier
Operationally, the bridge rectifier allows current flow through two of its diodes during each...
Wheatstone Bridge
Thus, for accurate resistance measurements, a...